Infosys share buyback: Company set for its biggest Rs 18,000 crore offer ever; what to know before Nov 14 record date

Infosys, India’s second-largest IT services company, is gearing up for its biggest-ever share buyback worth Rs 18,000 crore, with November 14, 2025, set as the record date to determine eligible shareholders, according to an ET report.The Bengaluru-headquartered company will repurchase 10 crore equity shares, representing 2.41% of its paid-up capital, at Rs 1,800 per share…

Read More

Union Budget 2026 income tax: Why focus should shift from tax rates to real ease of compliance

Over the last few years, personal taxation has seen meaningful changes, particularly in the form of revised slabs By Sureshkumar SIndia enters the Union Budget 2026 on relatively strong economic footing, supported by steady growth, resilient domestic demand and continued investment in digital public infrastructure. Over the last few years, personal taxation has seen meaningful…

Read More

Ritiesh Deshmukh was insistent I direct ‘Mastiii 4’: Milap Zaveri | Hindi Movie News

Director Milap Zaveri candidly shares his career low after Satyameva Jayate 2’s failure, highlighting the crucial support from industry stalwarts like Indra Kumar and Bhushan Kumar. He expresses excitement for Mastiii 4, Bollywood’s sole adult comedy franchise reaching its fourth installment, promising a script that unleashes the cast’s comedic brilliance. Writer-director Milap Zaveri, fresh from…

Read More

Conduct independent probe in Pune-Bangalore highway crash: SC panel to Maharashtra government | India News

NEW DELHI: The Supreme Court Committee on Road Safety on Monday directed the Maharashtra government to carry out a “thorough and independent crash investigation” into the recent accident on the Pune–Bangalore highway in which eight people were burnt alive and 13 others injured. It asked the state to get the probe conducted by an institute…

Read More

Lower drug prices for Americans! Trump seals deal with AstraZeneca; some medicines at discounts of up to 80%

US President Donald Trump on Friday announced reaching a deal with AstraZeneca, which would lower the cost of some prescription drugs for millions of Americans.The agreement will see the company sell certain medicines at reduced prices to the government’s Medicaid health plan in exchange for tariff relief. This follows a similar arrangement made with Pfizer…

Read More